Subscribe to our Newsletters !!
When handling common problems in bacterial culturi
Pharmaceutical laboratories have been adopting imm
Relevant codes should be used when coding fibromya
Alembic Pharmaceuticals Limited appoints Mr. Manis
The importance of comparing the treatment of asthm
It is important to understand that natural remedie
In a world constantly in motion, Microbioz India r
Johnson & Johnson’s newly authorized COVID-19 vaccine has begun shipping and its top executive said on Monday that Americans should have the ability to get the single-dose shot over the next 24 to 48 hours, including a third vaccine in america.
The drugmaker intends to deliver 4 million vaccine doses this week, 20 million by the end of March and 100 million doses by June, J&J Chief Executive Office Alex Gorsky said in interviews with NBC News’ Today program and CNBC.
“Over the next 24 to 28 hours, Americans should begin receiving shots . They’re literally rolling out with the trucks as we speak,” he said to NBC News.
J&J’s vaccine requires only one shot, while other licensed vaccines require two.
“The quicker we can get everyone vaccinated, the lower the chance for mutations and variations,” Gorsky said in a CNBC interview.
The coronavirus has been circulating around the globe for more than a year and lately, new virus variations have arisen against which the J&J vaccine and others appear less effective. Public health officials say a global vaccination effort can help stem these variants from growing.
Gorsky said J&J was confident that its vaccine could have a”robust response” against those emerging variations, based on its clinical trial in countries including South Africa and Brazil where worrisome variants were circulating.
The business is developing a version of its vaccine to target the version found in South Africa, and will be prepared to start late-stage trials through this summer.
Pfizer and German spouse BioNTech and Moderna Inc have FDA-authorized two-dose vaccines.
Shares of J&J were up nearly 2% in premarket trading after the U.S. Food and Drug Administration gave it emergency use authorization on Saturday.
McKesson Corp said on Monday it had started distributing the vaccine.